MOH — authorised 16 March 1976
- Marketing authorisation holder: XSPIRE
- Status: likely_approved
MOH authorised Nalfon on 16 March 1976
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 16 March 1976.
XSPIRE holds the Israeli marketing authorisation.